News
01-25-2011, 03:10 PM
The experimental breast cancer drug Iniparib appears to shrink tumors, increase the time tumors take to progress, and prolongs survival in women with triple negative breast cancer.
More... (http://www.healthcentral.com/breast-cancer/news-564713-98.html)
More... (http://www.healthcentral.com/breast-cancer/news-564713-98.html)